Literature DB >> 10819294

Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure.

W Hu1, S Ohyama, K Hasumi.   

Abstract

Two novel staplabin analogs, SMTP-7 and -8, have been isolated from cultures of Stachybotrys microspora IFO 30018. Spectroscopic analyses showed that the SMTP-7 molecule consisted of two identical staplabin core structures and ornithine which bridges the two partial structures. In the SMTP-8 molecule, the bridging unit was lysine. At concentrations of 80 approximately 150 microM, the two compounds caused 2- to 12-fold increase in urokinase-catalyzed plasminogen activation, fibrin binding of plasminogen, and urokinase- and plasminogen-mediated fibrinolysis. These activities of SMTP-7 and -8 were two to ten times higher than those of staplabin and previously isolated SMTPs, which exerted such effects at concentrations ranging from 150 to 800 microM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819294     DOI: 10.7164/antibiotics.53.241

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

2.  A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice.

Authors:  Keita Shibata; Terumasa Hashimoto; Koji Nobe; Keiji Hasumi; Kazuo Honda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-03       Impact factor: 3.000

3.  Structure-activity relationships of the plasminogen modulator SMTP with respect to the inhibition of soluble epoxide hydrolase.

Authors:  Naoki Matsumoto; Eriko Suzuki; Kota Tsujihara; Yuuichi Nishimura; Keiji Hasumi
Journal:  J Antibiot (Tokyo)       Date:  2015-05-13       Impact factor: 2.649

Review 4.  Progress in Isoindolone Alkaloid Derivatives from Marine Microorganism: Pharmacology, Preparation, and Mechanism.

Authors:  Sijin Hang; Hui Chen; Wenhui Wu; Shiyi Wang; Yiwen Fang; Ruilong Sheng; Qidong Tu; Ruihua Guo
Journal:  Mar Drugs       Date:  2022-06-20       Impact factor: 6.085

5.  SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates.

Authors:  Hironobu Sawada; Naoko Nishimura; Eriko Suzuki; Jie Zhuang; Keiko Hasegawa; Hiroyuki Takamatsu; Kazuo Honda; Keiji Hasumi
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

6.  SMTP (Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats.

Authors:  Weimin Hu; Ritsuko Narasaki; Naoko Nishimura; Keiji Hasumi
Journal:  Thromb J       Date:  2012-01-09

7.  Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeys.

Authors:  Eriko Suzuki; Naoko Nishimura; Tetsuya Yoshikawa; Yudai Kunikiyo; Keiko Hasegawa; Keiji Hasumi
Journal:  Pharmacol Res Perspect       Date:  2018-12-05

Review 8.  Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.

Authors:  Keiji Hasumi; Eriko Suzuki
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

9.  Protective Effect of Stachybotrys microspora Triprenyl Phenol-7on the Deposition of IgA to the Glomerular Mesangium in Nivalenol-induced IgA Nephropathy Using BALB/c Mice.

Authors:  Sayaka Kemmochi; Hitomi Hayashi; Eriko Taniai; Keiji Hasumi; Yoshiko Sugita-Konishi; Susumu Kumagai; Kunitoshi Mitsumori; Makoto Shibutani
Journal:  J Toxicol Pathol       Date:  2012-06       Impact factor: 1.628

10.  Producing Novel Fibrinolytic Isoindolinone Derivatives in Marine Fungus Stachybotrys longispora FG216 by the Rational Supply of Amino Compounds According to Its Biosynthesis Pathway.

Authors:  Ying Yin; Qiang Fu; Wenhui Wu; Menghao Cai; Xiangshan Zhou; Yuanxing Zhang
Journal:  Mar Drugs       Date:  2017-07-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.